Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases

Figure 2

ROC curves of HMGB1 for distinguishing patients with asbestos-related diseases (ADRs) from AE individuals or healthy controls. Four ROCs with high AUC (>0.800) were selected and shown in panels (a), (b), (c), and (d). ROC: receive operation curve; AE: asbestos-exposed; AUC: area under the curve; vs.: versus; Y: years. See details in text.

(a)

(b)

(c)

(d)